Found: 3
Select item for more details and to access through your institution.
Early assessment of circulating tumor DNA after curative‐intent resection predicts tumor recurrence in early‐stage and locally advanced non‐small‐cell lung cancer.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 2, p. 527, doi. 10.1002/1878-0261.13116
- By:
- Publication type:
- Article
Personalized Treatment Selection and Disease Monitoring Using Circulating Tumor DNA Profiling in Real-World Cancer Patient Management.
- Published in:
- Diagnostics (2075-4418), 2020, v. 10, n. 8, p. 550, doi. 10.3390/diagnostics10080550
- By:
- Publication type:
- Article
Stringent Base Specific and Optimization-Free Multiplex Mediator Probe ddPCR for the Quantification of Point Mutations in Circulating Tumor DNA.
- Published in:
- Cancers, 2021, v. 13, n. 22, p. 5742, doi. 10.3390/cancers13225742
- By:
- Publication type:
- Article